Reckitt to launch £250m second tranche of share buyback in October

Reckitt Benckiser Group plc is initiating the second £250 million tranche of its £1 billion share buyback program, set to commence after the first tranche concludes in October 2025. This phase, managed by BNP Paribas and expected to complete by January 30, 2026, aims to enhance shareholder returns and reduce the company's share capital by repurchasing shares on the London Stock Exchange for treasury and eventual cancellation.

Analysis

Reckitt Benckiser Group plc is systematically executing its capital return strategy by advancing with the second £250 million tranche of its previously announced £1 billion share buyback program. This tranche is scheduled to commence after October 2025 and conclude by January 30, 2026, providing investors with clear visibility into the company's near-term capital allocation policy. The repurchased shares are designated for cancellation, a move that will mechanically reduce the total share count and thus be accretive to earnings per share for the remaining shareholders. This action, operating under shareholder authority granted in May 2025 and adhering to UK regulations, signals management's confidence in the company's financial position and commitment to enhancing shareholder value. The continuation of the larger program reinforces a disciplined and predictable approach to capital returns.

Key Decisions for Investors

• Investors should interpret the steady execution of the substantial £1 billion buyback program as a strong signal of management's confidence in the company's intrinsic value and future cash flow generation.
• The buyback creates a consistent source of demand for the company's stock on the London Stock Exchange, which could provide a degree of price support, particularly during the active repurchase window between October 2025 and January 2026.
• Valuation models should be adjusted to reflect the impending reduction in share count, as the accretive effect on earnings per share will become more significant as the program progresses.
• Monitor for company announcements after January 2026 regarding the deployment of the remaining £500 million authorized for repurchase, as this will be a key indicator of the company's longer-term capital return policy.